Report
Sam Hudson, CFA

Another robust quarter

WBA reported another quarter of strong US script volume growth (+4.0%), with sales +2.5% ahead of expectations, benefiting from the formation of AllianceRx Wagreens Prime, the acquisition of RAD stores and FX tailwinds. Operating margins were ~10bps below expectations (in-line with AE), but adj. EPS was still $0.18 ahead, with a lower tax rate (~16.5%) adding ~$0.07 vs. AE. FY18 EPS guidance was implicitly raised $0.10 at the low-end, with the mid-point now $0.13 above consensus. Many moving parts, but another robust quarter from WBA, with the company also announcing that it had completed the RAD store acquisition after Q-end.
Underlying
Walgreens Boots Alliance Inc

Walgreens Boots Alliance is a holding company. Through its subsidiaries, the company is engaged in retail and wholesale pharmacy. The company's operations are organized into three divisions, which are also its reportable segments: Retail Pharmacy USA; Retail Pharmacy International; and Pharmaceutical Wholesale. The Retail Pharmacy USA division has pharmacy-led health and beauty retail offerings. The Retail Pharmacy International division has pharmacy-led health and beauty retail businesses. The Pharmaceutical Wholesale division, which mainly operates under the Alliance Healthcare brand, supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers and hospitals.

Provider
Atlantic Equities
Atlantic Equities

Formed in 2003 by an established team from Cazenove, one of the most respected investment banks in the UK, Atlantic Equities conducts and publishes fundamental, bottom up research on mid and large cap US companies.

Atlantic provide order execution through a wide range of DMA products and algorithmic trading suites.

Analysts
Sam Hudson, CFA

Other Reports on these Companies
Other Reports from Atlantic Equities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch